New generation vaccines effective against mpox have a better safety profile. The biggest obstacle for Africa now is availability and cost.
- Professor in Vaccinology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Countries have to weigh up the cost of vaccinating everybody versus the cost of treating the disease.
Occasionally, a mutation will give the virus a better chance of surviving and reproducing itself, and will result in a new population (known as a new lineage)
Contact Anna-Lise for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- Joined
